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considered when choosing this therapeutic approach for 
younger patients.  
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Purpose/Objective: Measuring, calculating, and reducing 
non-target doses present unique challenges with which many 
medical physicists may have limited experience. The 
American Association of Physicists in Medicine Task Group 
(TG) 158 report: 'Measurement and calculation of doses 
outside the treatment volume from external-beam radiation 
therapy' provides guidance for physicists in assessing and 
managing non-target doses. The primary objectives of this 
presentation are to (1) highlight major concerns with non-
target radiation, (2) provide a rough estimate of doses 
associated with different treatment approaches in clinical 
practice, and (3) to highlight techniques that may be 
considered for reducing non-target doses and (4) summarize 
TG-158 recommendations for both clinical and research 
practice. 
Materials and Methods: The TG-158 report reviewed 
approximately 300 publications in the literature to provide 
guidance on management of non-target doses. This 
presentation will summarize key components of the report 
and its recommendations.  
Results: The Task Group 158 report generated guidance for 
physicists in terms of doses to non-target structures, 
dosimetry and computational techniques for assessing non-
target doses, as well as potential treatment and patient 
management options for minimizing non-target doses. This 
was done by addressing the following charges: 
1. Highlight major concerns with non-target radiation 
2. Provide a rough estimate of doses associated with 
different treatment approaches in clinical practice 
3. Discuss the uses of dosimeters and phantoms for measuring 
photon, electron, and neutron exposures  
4. Discuss the use of calculation techniques (including Monte 
Carlo) for dosimetric evaluations 
5. Highlight techniques that may be considered for reducing 
non-target doses 
6. Make recommendations for clinical and research practice 
This presentation will summarize the Task Group report’s 
findings on topics 1, 2, 5, and 6 from the list above. Topics 3 
and 4, measurement and calculation of non-target doses, are 
each broad topics and separate abstracts detailing these 
topics are separate submitted abstracts at this meeting. 
Conclusions: This presentation will summarize key 
components of the AAPM TG-158 report and its 
recommendations.  
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Purpose/Objective: The literature has reported that some 
TPSs underestimate the dose outside the radiation field edge 
(out-of-field). Sources of out-of-field dose are phantom 
scatter, head scatter and head and MLC leakage and 
transmission. The issues associated with inaccurate out-of-
field dose reporting is with secondary cancer risk estimation, 
incorrect clinical decisions based on inaccurate OAR doses, 
incorrect estimation of dose to implanted devices and 
pregnant patients, etc. The aim of this study was to 
understand how different detectors respond to out-of-field 
radiation and compare measurements to Monte Carlo (MC). 
Materials and Methods: Profiles extending ~20 cm outside 
the radiation field edge and divergent out-of-field PDDs were 
acquired with a range of clinically available detectors (PTW 
microDiamond, EDiode, Pinpoint and SRS Diode) using a PTW 
MP3 Watertank for a 10x10cm2 field and 90cm SSD on an 
Elekta Precise linac operating at 6MV. X, Y and diagonal 
profiles were acquired at depths of dmax, 5, 10, 15 and 
20cm. Divergent PDDs were acquired at 1,2,3,4,5,7,10 and 15 
cm from the field edge using in-house software to correct for 
daily beam inclination changes. A MC linac model was 
created in BEAMnrc and dose calculations were performed 
using DOSXYZnrc.  
Results: All profiles were normalised to their respective CAX 
dose and agreed to within 0.5% at depths of dmax and 5cm 
and within 1% at depths between 5 and 20cm. Comparison of 
the measured out-of-field profiles to MC reveals agreement 
to within 1%. The SRS diode deviates from both MC and the 
other detectors at depths greater than 5 cm better 
agreement is observed at shallower depths. 
All divergent PDDs were normalised to their respective 
average dose. The divergent PDDs (Fig. 1) display an initial 
build-up and down portion followed by a second smaller 
build-up region for PDDs acquired at 1-10cm from the field 
edge.  
